National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 4/19/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Teva

None

None

4/5/2013

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Astellas;
Clavis;
Cyclacel;
CytRx;
Lilly Pharmaceuticals

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

5/19/2013

Frederick R. Appelbaum, MD

None

None

None

None

3/26/2013

Daniel A. Arber, MD

None

US Diagnostic Standards

None

None

4/29/2013

Eyal Attar, MD

Cincinnati Children`s Hospital;
Massachusetts General Hospital

Celgene Corporation;
Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Advanced Medical;
Wallachbeth

ARIAD Pharmaceuticals, Inc.

None

2/9/2014

Uma Borate, MD

Eli Lilly and Company;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.

Alexion Pharmaceuticals, Inc.

None

None

4/8/2014

Steven E. Coutre, MD

None

Celgene Corporation

None

None

5/16/2013

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Jeffrey Lancet, MD

Celgene Corporation

Celgene Corporation;
Spectrum Pharmaceuticals

None

None

8/6/2012

Lori J. Maness, MD

Cyclacel, LTD

None

None

None

1/7/2014

Guido Marcucci, MD

None

None

None

None

8/15/2012

Michael G. Martin, MD

None

None

None

None

9/18/2013

Mary Ellen Martin, MD

       

Pending

Joan S. McClure, MS

None

None

None

None

8/13/2013

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/15/2014

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

5/30/2013

Daniel A. Pollyea, MD, MS

Celgene Corporation;
Abbvie

ARIAD Pharmaceuticals, Inc.;
Celgene Corporation;
Celgene Corporation;
Agios

None

None

3/14/2014

Farhad Ravandi, MD

Bayer HealthCare;
Celgene Corporation;
Celgene Corporation;
Merck & Co., Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.;
Sunesis Pharmaceuticals, Inc.

Amgen Inc.;
Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.;
Sunesis Pharmaceuticals, Inc.

None

None

12/6/2013

Paul J. Shami, MD

Eisai Inc.;
Genzyme Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/28/2013

B. Douglas Smith, MD

None

ARIAD Pharmaceuticals, Inc.;
Clavis;
TEVA

None

None

1/19/2013

Courtney Smith

None

None

Johnson & Johnson;
OPKO

None

3/4/2014

Richard M. Stone, MD

Celgene Corporation;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.;
Agios;
Seattle Genetics

None

None

6/3/2013

Stephen A. Strickland, MD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Ambit;
Astellas Pharma US;
Celator Pharmaceuticals;
Cyclacel Pharmaceuticals;
sanofi-aventis U.S.;
Sunesis Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH;
Sunesis Pharmaceuticals, Inc.

None

None

3/25/2013

Martin S. Tallman, MD

None

Boehringer Ingelheim GmbH;
Agios Pharmaceuticals;
Seattle Genetics

None

None

1/7/2014

Eunice S. Wang, MD

None

Incyte

None

None

10/11/2013

Matthew Wieduwilt, MD, PhD

Celgene Corporation;
Pfizer Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

9/20/2013